Elevation of BMC academic leader and researcher will further clinical innovation, research, and equity at New England’s largest essential hospital
BOSTON – Anthony Hollenberg, MD, currently Physician-in-Chief at Boston Medical Center (BMC), has been appointed as the next President of the hospital by the BMC Board of Trustees to continue to advance the academic medical center’s leading role in clinical innovation, research, and health equity. This appointment fills a key position on the newly reimagined leadership team at Boston Medical Center Health System (BMCHS). Hollenberg, along with the Presidents of WellSense Health Plan and Clearway Health, will report to Alastair Bell, MD, MBA, President & CEO of BMCHS.
Hollenberg is a nationally recognized physician-scientist who specializes in endocrinology. He was named Physician-in-Chief of BMC and the John Wade Professor and Chair of the Department of Medicine at Boston University Chobanian & Avedisian School of Medicine in 2022. Before joining BMC and Boston University, Hollenberg served as Chair of the Joan and Sanford I. Weill Department of Medicine at Weill Cornell Medicine and Physician-in-Chief at NewYork-Presbyterian/Weill Cornell Medical Center.
“Dr. Hollenberg’s extensive leadership background at academic medical centers, demonstrated experience as a highly accomplished physician-researcher, and his longstanding commitment to clinical innovation and health equity make him ideal to drive BMC forward as a premier academic medical center,” Bell said. “As our health system rewrites how to best deliver care to our patients and members, Dr. Hollenberg will further advance systems of care to ensure BMC remains a strong, trusted, and sustainable organization.”
Hollenberg currently oversees the Department of Medicine, BMC’s largest clinical department, encompassing a wide range of patient care and research.
“Throughout his time leading the Department of Medicine, Dr. Hollenberg has partnered with colleagues from across the organization to drive healthier outcomes for our patients and communities,” said Martha Samuelson, the chair of the BMC Board of Trustees. “He will further cement our hospital and health system’s role as a national model in equitable care.”
BMCHS is reshaping how care is delivered to patients and members in a fully integrated system, from cutting-edge clinical treatments to groundbreaking research to deep community engagement. BMC models a new kind of excellence in health care where clinical innovation meets health equity.
“I’m truly honored to lead BMC and our world-class clinical, research, administrative and operational team members as our health system reimagines the future of equitable, expert care for our patients and members,” Hollenberg said. “I look forward to hearing from my colleagues across the hospital to build on their ideas and expertise to meet the health and social challenges of the patients we serve. Every role at the hospital is critical to helping our patients and communities thrive.”
Hollenberg’s clinical work and research has focused on thyroid disorders, investigating the physiological and molecular mechanisms by which thyroid hormones regulate metabolism, including body weight. Additionally, his laboratory explores the underpinnings of thyroid gland development. He has published more than 100 original studies in journals and contributed 30 book chapters and reviews.
Hollenberg received his bachelor’s degree from Harvard College and his medical degree from the University of Calgary. He completed his residency in Internal Medicine at Beth Israel Deaconess Medical Center, followed by a clinical and research fellowship at Massachusetts General Hospital.
BMC and Boston University Chobanian & Avedisian School of Medicine will launch a search to fill Hollenberg’s role as Physician-in-Chief and Chair of the Department of Medicine.